Product information and disease description Product description Product information

Effect of tavapadon on quality measures

4 evidence topics · 3 sources

Product-specific effect on quality measures

No evidence found.

American Academy of Neurology measure: assessment of impulse control disorders in patients taking Parkinson's disease medications

“Percentage of all patients with a diagnosis of PD currently taking dopaminergic medications who were assessed for impulse control disorder once during the measurement period” (opens the source at this quote in a new tab)
“Parkinson’s disease medications include any preparation containing levodopa, dopamine agonists, amantadine, MAOB inhibitors” (opens the source at this quote in a new tab)
“Impulse control disorders (ICDs), including pathological gambling, compulsive shopping, compulsive sexual behaviors, and binge eating occur in approximately 14-17% of people with PD. ICDs occur mainly with dopaminergic medications, especially the dopamine agonists.” (opens the source at this quote in a new tab)

American Academy of Neurology measure: assessment of dopaminergic medication-related motor complications

“Percentage of all patients diagnosed with PD who were assessed for dopaminergic medication-related motor complications once during the measurement period” (opens the source at this quote in a new tab)
“In a 2013 study by Baek et al. reviewing compliance with quality measure recommendations, it was noted provider compliance rate for every visit for Parkinson’s disease medication-related motor complications (e.g., wearing off, dyskinesia, or off-time) was 23.5%.” (opens the source at this quote in a new tab)

Merit-based Incentive Payment System 2026 measure: cognitive assessment in Parkinson's disease

“Percentage of all patients with a diagnosis of Parkinson’s disease (PD) who were assessed for cognitive impairment or dysfunction once during the measurement period.” (opens the source at this quote in a new tab)

Merit-based Incentive Payment System 2026 measure: rehabilitative therapy referral in Parkinson's disease

“Percentage of all patients with a diagnosis of Parkinson’s Disease (PD) who were referred to physical, occupational, speech, or recreational therapy once during the measurement period.” (opens the source at this quote in a new tab)